Presented By Professor Hashim U. Ahmed

London | 24 - 25 April 2020

Annoucement Week Registration Discount (-30%) available until midnight 18/08/19
Register Online Now

Course Overview

Delegates will recieve the latest prostate cancer updates, challenges and controversies from our prestigious international faculty in state of the art auditorium hosted at Imperial College London

One-to-one training and hands on experiences are provided through our eclectic workshop programme where delegates may hone in on 1 of 16 specialised topics and recieve training from an expert practitioner

This course is accredited by the RCS(Eng) for 9.0 CPD points (pending)

Course objectives are focused on understanding and using MRI in the context of a urologist, the rationale behind deploying different methods of targeted biopsies, the principles of focal therapy and ablative energy selection, and proper case selection in the primary and salvage setting

The masterclass takes place at Imperial College London, in the South Kensington / ‘Albertopolis’ area of West London, a popular area for visitors for some of London's finest amenities and destinations.

The area is well-connected to Heathrow Airport which is directly accessible by train

The course runs from 0900 Friday 24/04/2019 - 1330 25/04/2019

The full registration fee for healthcare professionals in training is £250.00 / £450.00 registration fee for consultant healthcare professionals

Annoucement Week Registration Discount (-30%) available until midnight 18/08/19

Agenda Topics

Screening & Detection

Next-Generation Biomarkers

Professor Andrew Vickers
Memorial Sloan Kettering, New York

Using MRI For Screening

Professor Robert Nam
Sunnybrook Research Institute, Toronto

Optimising PSA

To be confirmed

Prostate Cancer Diagnostics: MRI

Foundations of MRI

Professor Shonit Punwani
University College London, London

PI-RADS and Likert

Professor Jelle Barentsz
Radboud University, Nijmegen

Biparametric or Multiparametric?

Professor Anwar Padhani
Paul Strickland Scanner Centre, London

Prostate Cancer Diagnostics: Biopsy

Controversies in Prostate Biopsy

Professor Matthew Cooperberg
University of California, San Francisco

Risk prediction using biomarkers & imaging

To be confirmed

Gleason and the new ISUP Grade Groups

To be confirmed

Panel Discussion: Should Gleason 3+3 be called cancer?

Selecting An Ablative Technology


Multidisciplinary Case Review


The Future of Focal Therapy

Focal Surgery

Professor Arnauld Villers
University of Lille Nord de France, Lille

Focal Radiotherapy

Dr Vincent Khoo
The Royal Marsden Hospital, London

Focal Ablation

Professor Hashim Ahmed
Imperial College London, London